|
Orthologous residues
|
|
vimentin (human): S39‑p, vimentin (mouse): S39‑p, vimentin (rat): S39‑p, vimentin (hamster): S39‑p, vimentin (cow): S39‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
astrocyte-'brain, cerebrum'
|
|
Cellular systems studied:
primary cultured cells
|
|
Species studied:
rat
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
PGE2a
|
|
|
|
increase
|
|
|
ionomycin
|
|
|
|
increase
|
|
|
EGTA
|
ionomycin
|
|
|
inhibit treatment-induced increase
|
|
|
EGTA, calyculin A
|
ionomycin
|
|
|
augment treatment-induced increase
|
|
|
okadaic acid, EGTA
|
ionomycin
|
|
|
inhibit treatment-induced increase
|
|
|